Concepedia

Don K. Hamlin

DK

Statistics

Publications

7

Citations

457

H-Index

7

Active since

2000

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

Don K. Hamlin is an author at Fred Hutch Cancer Center specializing in glycobiology, engineering, and radiation oncology.

Top concepts

Publications per year

2000–2010

7

Publications

7

A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts

Oliver W. Press, Melissa C. Corcoran, Krishnan Subbiah et al. · Blood · 2001 · 149 citations · Full text

Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease

Steven I. Park, Jaideep Shenoi, John M. Pagel et al. · Blood · 2010 · 72 citations · Full text

Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts.

Krishnan Subbiah, Don K. Hamlin, John M. Pagel et al. · PubMed · 2003 · 68 citations

A Streptavidin−Biotin Binding System That Minimizes Blocking by Endogenous Biotin

Kevin J. Hamblett, Brian B. Kegley, Don K. Hamlin et al. · Bioconjugate Chemistry · 2002 · 57 citations

, , +17

Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomas

John M. Pagel, Yukang Lin, Nathan Hedin et al. · Blood · 2006 · 47 citations · Full text

Rows per page

1–5 of 7